Nagoya City University Hospital /ID# 256086

Nagoya, Aichi-ken 467-8602

1 studies enrolling now · 1 studies all time

What they study most

Immunoglobulin Light Chain (AL) Amyloidosis

Studies at this site

• A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion — Recruiting now